Electroactive microneedle augmented stem cell therapy in myocardial infarction.

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cardiovascular Research

Background:

• Ischemic heart disease presents a significant global health challenge.
• Current stem cell therapies for cardiac repair face limitations in engraftment and efficacy.
• Excessive cardiomyocyte and fibroblast activation worsens outcomes post-myocardial infarction.

Purpose of the Study:

• To develop an implantable electroactive device for enhanced stem cell therapy in cardiac repair.
• To improve stem cell engraftment and stimulate resident cardiomyocyte self-repair.
• To investigate the potential of piezoelectric stimulation for heart recovery.

Main Methods:

• Utilized a piezoelectric microneedle patch for efficient delivery of mesenchymal stem cells (1.5 × 10^5) to infarcted cardiac tissue.
• Incorporated a poly(l-lactic) acid microneedle matrix to provide piezoelectric stimulation.
• Evaluated the device's efficacy in a rat heart infarction model.

Main Results:

• The device facilitated sustained stem cell delivery and paracrine effects.
• Piezoelectric stimulation potentiated stem cells and enhanced cardiomyocyte self-repair.
• Observed suppression of inflammatory monocytes, reduced cardiomyocyte necrosis, and improved cardiac remodeling.

Conclusions:

• The implantable electroactive device represents a promising strategy for heart recovery post-infarction.
• Combining stem cell delivery with piezoelectric stimulation offers a novel approach to cardiac regeneration.
• This technology has the potential to overcome limitations of traditional stem cell therapies for ischemic heart disease.